Maximising the Impact of Horizon 2020 Projects
Join RKEO staff at this free webinar presented by Dr Eugene Sweeney of the EU Intellectual Property Rights Helpdesk. This will take place on Wednesday, 8th July in Room P403, from 9:30 to 10:45
According to the website, in this 60 minute session, you will:
Learn more about exploitation of IP rights in H2020 projects. This webinar gives an overall view of the creation and the development of IP rights both through and after the duration of an H2020 project. The most common planning mistakes will be analysed and some practical tips will be given, so that you can have the best possible results from an H2020 project.
Learning Objectives
After the training, participants should have a better understanding of the following:
- The IP in the Consortium Agreements: a particular regard to the results of the research.
- Which are the best means to maximize the value of your IP?
- Assessing your IP: How can you estimate the value of your IP?
- Which criteria should be taken into account when it comes to determine how much your IP is worth?
- Which are the best exploitation strategies and business plans for entering the market?
- Reap the rewards of your IP: licensing and post deal managing.
As part of the webinar, there will be around 15 minutes after the presentation for Q&A. Depending on attendees, there may be the opportunity for BU-related discussions after the webinar.
To attend, please contact Dianne Goodman in RKEO to secure your place.
























BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease